New drugs, new rashes: update on cutaneous drug reactions.
Burgin
Susan
S
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D044966:Anti-Retroviral Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D044966:Anti-Retroviral Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha